The Biotechnology industry is part of the Healthcare sector. It holds 1,512 US-listed stocks. Their average AI MoonshotScore is 56 out of 100. The top 3 names are ETON, EXEL, KNSA.
Biotechnology Stocks
Complete list of 1,512 Biotechnology industry stocks with AI-powered MoonshotScore analysis, market-hours price data, and provider-sourced market insights. Part of the Healthcare sector.
Biotechnology Industry Overview
The Biotechnology industry, part of the Healthcare sector, comprises 1,512 publicly traded companies with a combined market capitalization of $993.8B.
Today's market sentiment for Biotechnology stocks is Bearish, with 28 stocks advancing and 169 declining. The average price movement across the industry is -3.28%.
The average AI MoonshotScore across Biotechnology stocks is 56/100. MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). Weights are rescaled to 100 when all five pillars have data: 28.3%, 21.7%, 19.6%, 17.4% and 13.0% of the score. It reads no news-sentiment or analyst data, and it is not a probability of future returns.
How Are Biotechnology Stocks Distributed by Market Cap?
How Biotechnology companies are distributed across market capitalization tiers.
Frequently Asked Questions
How many stocks are in the Biotechnology industry?
There are currently 1,512 publicly traded companies classified under the Biotechnology industry within the Healthcare sector. The tracked companies carry a combined market capitalization of $993.8B, with 28 advancing and 169 declining in today's trading.
Which Biotechnology stocks rank highest by MoonshotScore?
Based on our AI MoonshotScore analysis, the top-rated Biotechnology stocks are ETON, EXEL, KNSA. Always conduct your own research before investing.
What are the largest Biotechnology companies by market cap?
The largest Biotechnology companies by market capitalization are NVO ($166.69B), VRTX ($132.01B), REGN ($95.52B). Across the tracked list, the median market capitalization is $583M — a gauge of how top-heavy the industry is beyond its largest names.
What is the average MoonshotScore for Biotechnology stocks?
The current average MoonshotScore for the Biotechnology industry is 56/100. The strongest current score in the industry is 98/100. MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). Weights are rescaled to 100 when all five pillars have data: 28.3%, 21.7%, 19.6%, 17.4% and 13.0% of the score. It reads no news-sentiment or analyst data, and it is not a probability of future returns.
How does the Biotechnology industry perform compared to the overall market?
Biotechnology stocks are tracked against broader market benchmarks. You can compare sector and industry performance on our Market Sectors dashboard.
Our Analysis Methodology
Stock Expert AI rates eligible U.S.-listed companies with the MoonshotScore, a proprietary 0–100 composite rating. V2 is the only current model: eligible companies are scored against their sector peers across five pillars — business quality, financial safety, valuation, growth durability, and momentum. MoonshotScore V2 covers eligible common stocks and ADRs on NASDAQ, NYSE and AMEX. OTC listings are outside the scheduled universe; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry no MoonshotScore.
MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). Weights are rescaled to 100 when all five pillars have data: 28.3%, 21.7%, 19.6%, 17.4% and 13.0% of the score. It reads no news-sentiment or analyst data, and it is not a probability of future returns.
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Each price is the last quote we recorded, shown with the trading session it belongs to. Pages are served from a cache, so the copy you are reading can lag that quote. Each quote is a provider snapshot, not an exchange feed.
Sector names are the familiar eleven, but the classification itself is our data provider's, not GICS, and departs from it in places — mortgage REITs, education and packaging are filed the way GICS files them; the rest follow the provider. Companies are assigned to one sector and to one of 50+ industries by their primary revenue source.
Explore More
Data is provided for informational purposes only and should not be considered investment advice. Stock prices, market capitalizations, and MoonshotScores are updated throughout the trading day. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
Which stocks are in the Biotechnology industry? (Page 1 of 8)
1–200 of 1,512 shown| Stock | Price | Change | Volume | Market Cap | MoonshotScore | Sector |
|---|---|---|---|---|---|---|
|
ETON
Eton Pharmaceuticals, Inc.
|
$61.36 | -1.02% | 387.6K | $1.77B | 98 | Healthcare |
|
EXEL
Exelixis, Inc.
|
$64.63 | -1.82% | 2.04M | $15.77B | 98 | Healthcare |
|
KNSA
Kiniksa Pharmaceuticals, Ltd.
|
$93.89 | +0.38% | 545.1K | $7.38B | 98 | Healthcare |
|
ADMA
ADMA Biologics, Inc.
|
$13.17 | -1.27% | 2.45M | $2.92B | 97 | Healthcare |
|
AUPH
Aurinia Pharmaceuticals Inc.
|
$14.70 | -1.28% | 1.34M | $1.97B | 97 | Healthcare |
|
NRIX
Nurix Therapeutics, Inc.
|
$12.85 | -5.55% | 2.43M | $1.40B | 97 | Healthcare |
|
UTHR
United Therapeutics Corporation
|
$559.10 | -3.16% | 393.7K | $23.81B | 97 | Healthcare |
|
ARGX
argenx SE
|
$925.70 | -1.73% | 235.3K | $58.21B | 96 | Healthcare |
|
ASND
Ascendis Pharma A/S
|
$252.73 | -1.26% | 602.9K | $16.58B | 96 | Healthcare |
|
HRMY
Harmony Biosciences Holdings, Inc.
|
$32.59 | -1.18% | 582.6K | $1.91B | 96 | Healthcare |
|
INVA
Innoviva, Inc.
|
$18.41 | +0.00% | 1.15M | $1.31B | 96 | Healthcare |
|
KRYS
Krystal Biotech, Inc.
|
$308.89 | -2.19% | 286.7K | $9.15B | 96 | Healthcare |
|
HALO
Halozyme Therapeutics, Inc.
|
$91.35 | -1.82% | 1.43M | $10.41B | 95 | Healthcare |
|
NBIX
Neurocrine Biosciences, Inc.
|
$156.59 | -3.85% | 1.35M | $15.85B | 95 | Healthcare |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$923.34 | -2.35% | 718.1K | $95.52B | 95 | Healthcare |
|
VCEL
Vericel Corporation
|
$57.52 | -1.27% | 582.3K | $2.94B | 95 | Healthcare |
|
TECH
Bio-Techne Corporation
|
$72.67 | -0.04% | 3.65M | $11.42B | 92 | Healthcare |
|
CORT
Corcept Therapeutics Incorporated
|
$63.62 | -2.09% | 1.09M | $6.96B | 91 | Healthcare |
|
FENC
Fennec Pharmaceuticals Inc.
|
$13.45 | +0.90% | 460.1K | $474.85M | 91 | Healthcare |
|
INCY
Incyte Corporation
|
$114.63 | -1.07% | 1.54M | $23.36B | 91 | Healthcare |
|
ZVRA
Zevra Therapeutics, Inc.
|
$8.76 | -3.42% | 1.15M | $521.26M | 91 | Healthcare |
|
PLX
Protalix BioTherapeutics, Inc.
|
$2.90 | -5.23% | 1.23M | $244.52M | 90 | Healthcare |
|
TGTX
TG Therapeutics, Inc.
|
$63.34 | -2.37% | 2.09M | $9.57B | 90 | Healthcare |
|
VRTX
Vertex Pharmaceuticals Incorporated
|
$520.66 | -2.94% | 1.15M | $132.01B | 90 | Healthcare |
|
ARQT
Arcutis Biotherapeutics, Inc.
|
$26.36 | -2.98% | 1.29M | $3.33B | 89 | Healthcare |
|
VCYT
Veracyte, Inc.
|
$25.04 | -2.07% | 1.87M | $2.02B | 89 | Healthcare |
|
PTGX
Protagonist Therapeutics, Inc.
|
$121.40 | -2.11% | 600.7K | $7.92B | 88 | Healthcare |
|
RIGL
Rigel Pharmaceuticals, Inc.
|
$40.09 | -2.67% | 352.0K | $754.89M | 88 | Healthcare |
|
NVO
Novo Nordisk A/S
|
$37.82 | -2.70% | 13.04M | $166.69B | 87 | Healthcare |
|
EWTX
Edgewise Therapeutics, Inc.
|
$39.91 | -3.07% | 1.19M | $4.37B | 84 | Healthcare |
|
CAI
Caris Life Sciences, Inc.
|
$17.58 | -5.18% | 4.57M | $5.04B | 83 | Healthcare |
|
ICCC
ImmuCell Corporation
|
$10.92 | -2.41% | 18.7K | $99.28M | 82 | Healthcare |
|
RLYB
Rallybio Corporation
|
$15.47 | -0.32% | 50.5K | $86.63M | 82 | Healthcare |
|
ANAB
AnaptysBio, Inc.
|
$46.63 | -1.62% | 432.4K | $1.39B | 76 | Healthcare |
|
RPRX
Royalty Pharma plc
|
$67.72 | -1.38% | 2.81M | $38.94B | 73 | Healthcare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$143.82 | -2.71% | 2.33M | $19.26B | 72 | Healthcare |
|
ELVN
Enliven Therapeutics, Inc.
|
$46.53 | +0.26% | 933.6K | $3.42B | 72 | Healthcare |
|
GMAB
Genmab A/S
|
$51.35 | +0.75% | 4.34M | $31.66B | 72 | Healthcare |
|
ORMP
Oramed Pharmaceuticals Inc.
|
$3.69 | -5.14% | 272.9K | $160.46M | 72 | Healthcare |
|
LGND
Ligand Pharmaceuticals Incorporated
|
$286.85 | -0.03% | 259.8K | $5.74B | 71 | Healthcare |
|
CGEN
Compugen Ltd.
|
$1.84 | -2.13% | 188.2K | $174.29M | 69 | Healthcare |
|
LBRX
LB Pharmaceuticals Inc
|
$38.85 | -2.97% | 302.9K | $1.26B | 69 | Healthcare |
|
PHAR
Pharming Group N.V.
|
$11.54 | -5.10% | 10.5K | $816.78M | 69 | Healthcare |
|
ACAD
ACADIA Pharmaceuticals Inc.
|
$17.59 | -1.35% | 1.45M | $3.04B | 68 | Healthcare |
|
CLYM
Climb Bio, Inc.
|
$9.19 | -0.97% | 770.2K | $539.80M | 68 | Healthcare |
|
ERAS
Erasca, Inc.
|
$13.61 | -4.29% | 11.07M | $4.78B | 67 | Healthcare |
|
ORKA
Oruka Therapeutics, Inc.
|
$95.81 | -1.80% | 1.98M | $6.50B | 67 | Healthcare |
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
$26.02 | -0.69% | 1.14M | $3.35B | 66 | Healthcare |
|
MANE
Veradermics, Incorporated
|
$119.52 | -3.92% | 374.9K | $5.04B | 66 | Healthcare |
|
VOR
Vor Biopharma, Inc.
|
$19.19 | +3.62% | 1.55M | $1.18B | 66 | Healthcare |
|
BLTE
Belite Bio, Inc.
|
$127.38 | -15.65% | 1.04M | $5.17B | 64 | Healthcare |
|
SGP
SpyGlass Pharma, Inc. Common Stock
|
$30.43 | -1.14% | 108.9K | $1.02B | 64 | Healthcare |
|
MGTX
MeiraGTx Holdings plc
|
$7.98 | -1.97% | 1.01M | $779.89M | 63 | Healthcare |
|
SLS
SELLAS Life Sciences Group, Inc.
|
$13.66 | -8.08% | 15.37M | $2.78B | 63 | Healthcare |
|
TRVI
Trevi Therapeutics, Inc.
|
$13.35 | -2.70% | 2.09M | $1.90B | 63 | Healthcare |
|
TNGX
Tango Therapeutics, Inc.
|
$21.73 | -4.32% | 1.74M | $3.68B | 62 | Healthcare |
|
ALPX
Alopexx, Inc.
|
$10.02 | +0.20% | 9.0K | $148.22M | 61 | Healthcare |
|
MBX
MBX Biosciences
|
$49.55 | -7.23% | 581.9K | $2.46B | 61 | Healthcare |
|
ANRO
Alto Neuroscience, Inc.
|
$25.37 | -4.30% | 522.5K | $1.02B | 60 | Healthcare |
|
HELP
Cybin Inc.
|
$6.11 | -9.88% | 2.50M | $487.68M | 60 | Healthcare |
|
INDP
Indaptus Therapeutics, Inc.
|
$2.82 | -9.90% | 239.4K | $433.16M | 60 | Healthcare |
|
NAGE
Niagen Bioscience Inc
|
$1.84 | -1.60% | 1.39M | $145.72M | 60 | Healthcare |
|
PRAX
Praxis Precision Medicines, Inc.
|
$300.43 | -3.37% | 806.1K | $8.40B | 60 | Healthcare |
|
QTTB
Q32 Bio Inc.
|
$8.34 | -1.65% | 476.7K | $249.57M | 60 | Healthcare |
|
ANTX
AN2 Therapeutics, Inc.
|
$5.08 | -2.68% | 332.7K | $192.75M | 59 | Healthcare |
|
IRON
Disc Medicine, Inc.
|
$75.14 | -1.27% | 561.6K | $3.42B | 59 | Healthcare |
|
NVCT
Nuvectis Pharma, Inc.
|
$19.39 | -2.27% | 301.6K | $666.80M | 59 | Healthcare |
|
BMRN
BioMarin Pharmaceutical Inc.
|
$61.42 | -0.02% | 5.21M | $11.90B | 58 | Healthcare |
|
BNTC
Benitec Biopharma Inc.
|
$7.92 | -2.76% | 268.7K | $285.88M | 58 | Healthcare |
|
DSGN
Design Therapeutics, Inc.
|
$9.02 | -3.22% | 281.9K | $577.61M | 58 | Healthcare |
|
RLMD
Relmada Therapeutics, Inc.
|
$2.62 | -15.76% | 2.25M | $279.54M | 58 | Healthcare |
|
CDT
CDT Equity Inc.
|
$0.23 | -13.89% | 836.7K | $437,033 | 57 | Healthcare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$9.67 | -3.40% | 927.5K | $815.69M | 57 | Healthcare |
|
DFTX
DFTX
|
$28.34 | -3.87% | 3.23M | $3.88B | 57 | Healthcare |
|
ENTX
Entera Bio Ltd.
|
$3.31 | +0.76% | 468.4K | $575.53M | 57 | Healthcare |
|
JBIO
Jade Biosciences, Inc.
|
$15.31 | +1.66% | 1.02M | $1.06B | 57 | Healthcare |
|
OKUR
OnKure Therapeutics, Inc.
|
$2.70 | -2.17% | 195.2K | $111.21M | 57 | Healthcare |
|
ORIC
ORIC Pharmaceuticals, Inc.
|
$7.36 | -4.42% | 1.46M | $764.94M | 57 | Healthcare |
|
PVLA
Palvella Therapeutics, Inc.
|
$142.85 | -2.00% | 192.7K | $2.09B | 57 | Healthcare |
|
STTK
Shattuck Labs, Inc.
|
$4.46 | -1.98% | 1.03M | $454.22M | 57 | Healthcare |
|
TYRA
Tyra Biosciences, Inc.
|
$20.12 | +1.98% | 467.6K | $1.39B | 57 | Healthcare |
|
AURA
Aura Biosciences, Inc.
|
$6.87 | -1.58% | 791.1K | $714.99M | 56 | Healthcare |
|
CTNM
Contineum Therapeutics, Inc.
|
$8.68 | -3.98% | 369.2K | $340.83M | 56 | Healthcare |
|
FULC
Fulcrum Therapeutics, Inc.
|
$3.69 | -0.54% | 2.16M | $281.85M | 56 | Healthcare |
|
GHRS
GH Research PLC
|
$17.53 | -5.55% | 298.8K | $1.20B | 56 | Healthcare |
|
GPCR
Structure Therapeutics Inc.
|
$16.13 | -5.78% | 786.1K | $1.15B | 56 | Healthcare |
|
IFRX
InflaRx N.V.
|
$1.04 | -4.59% | 472.1K | $153.26M | 56 | Healthcare |
|
PHVS
Pharvaris N.V.
|
$31.28 | -1.20% | 464.0K | $2.21B | 56 | Healthcare |
|
PLRZ
Polyrizon Ltd.
|
$9.31 | -8.42% | 4.8K | $22.61M | 56 | Healthcare |
|
TECX
Tectonic Therapeutic, Inc.
|
$20.73 | -1.47% | 268.8K | $405.26M | 56 | Healthcare |
|
XENE
Xenon Pharmaceuticals Inc.
|
$37.04 | -1.38% | 1.09M | $3.64B | 56 | Healthcare |
|
DMAC
DiaMedica Therapeutics Inc.
|
$8.25 | +2.87% | 313.5K | $445.15M | 55 | Healthcare |
|
ENLV
Enlivex Therapeutics Ltd.
|
$1.05 | -11.76% | 40.0K | $2.01M | 55 | Healthcare |
|
GRCE
Grace Therapeutics, Inc.
|
$1.71 | -0.58% | 153.9K | $35.97M | 55 | Healthcare |
|
RZLT
Rezolute, Inc.
|
$3.92 | -6.67% | 2.47M | $465.58M | 55 | Healthcare |
|
IMMX
Immix Biopharma, Inc.
|
$6.96 | -1.14% | 1.57M | $583.33M | 54 | Healthcare |
|
SGMT
Sagimet Biosciences Inc.
|
$9.08 | -5.61% | 1.50M | $648.02M | 54 | Healthcare |
|
ABVX
Abivax S.A.
|
$73.20 | -9.24% | 14.82M | $6.41B | 53 | Healthcare |
|
ANIX
Anixa Biosciences, Inc.
|
$2.60 | -4.06% | 227.2K | $90.39M | 53 | Healthcare |
|
AVXL
Anavex Life Sciences Corp.
|
$0.59 | -11.39% | 1.64M | $54.83M | 53 | Healthcare |
|
DRTS
Alpha Tau Medical Ltd.
|
$11.76 | +3.93% | 626.9K | $1.09B | 53 | Healthcare |
|
EQ
Equillium, Inc.
|
$1.06 | -5.36% | 567.9K | $87.26M | 53 | Healthcare |
|
IKT
Inhibikase Therapeutics, Inc.
|
$1.32 | +1.54% | 1.11M | $185.16M | 53 | Healthcare |
|
XBIT
XBiotech Inc.
|
$1.73 | +2.98% | 140.2K | $52.74M | 53 | Healthcare |
|
BOLD
Boundless Bio, Inc.
|
$2.32 | -2.52% | 147.9K | $54.78M | 52 | Healthcare |
|
EPRX
Eupraxia Pharmaceuticals Inc.
|
$5.80 | -5.23% | 361.6K | $390.16M | 52 | Healthcare |
|
IMNM
Immunome, Inc.
|
$15.69 | -5.54% | 1.06M | $1.85B | 52 | Healthcare |
|
MNPR
Monopar Therapeutics Inc.
|
$69.00 | -1.84% | 132.6K | $467.60M | 52 | Healthcare |
|
NBP
NovaBridge Biosciences
|
$0.83 | -5.66% | 991.5K | $96.28M | 52 | Healthcare |
|
NGNE
Neurogene Inc.
|
$22.15 | -3.40% | 178.3K | $458.53M | 52 | Healthcare |
|
PLYX
Polaryx Therapeutics, Inc. Common Stock
|
$1.33 | -11.92% | 49.4K | $66.30M | 52 | Healthcare |
|
CYPH
Cypherpunk Technologies Inc.
|
$1.41 | -18.02% | 16.17M | $210.15M | 51 | Healthcare |
|
IMRX
Immuneering Corporation
|
$3.38 | -2.03% | 1.45M | $218.90M | 51 | Healthcare |
|
PCVX
Vaxcyte, Inc.
|
$55.39 | -5.09% | 1.91M | $8.77B | 51 | Healthcare |
|
SMMT
Summit Therapeutics Inc.
|
$9.95 | -5.87% | 7.21M | $7.96B | 51 | Healthcare |
|
SVRA
Savara Inc.
|
$4.26 | -18.23% | 17.01M | $939.86M | 51 | Healthcare |
|
BCAX
Bicara Therapeutics Inc.
|
$8.44 | -7.46% | 814.5K | $560.31M | 50 | Healthcare |
|
COGT
Cogent Biosciences, Inc.
|
$26.71 | -3.70% | 2.12M | $4.65B | 50 | Healthcare |
|
DRUG
Bright Minds Biosciences Inc.
|
$20.40 | -1.45% | 166.0K | $201.23M | 50 | Healthcare |
|
KOD
Kodiak Sciences Inc.
|
$97.17 | -0.75% | 692.9K | $6.35B | 50 | Healthcare |
|
SLDB
Solid Biosciences Inc.
|
$6.25 | -2.95% | 1.56M | $697.57M | 50 | Healthcare |
|
ABUS
Arbutus Biopharma Corporation
|
$4.07 | -0.97% | 2.44M | $623.90M | 49 | Healthcare |
|
AVIR
Atea Pharmaceuticals, Inc.
|
$3.96 | +0.76% | 416.5K | $318.00M | 49 | Healthcare |
|
TTRX
Turn Therapeutics Inc.
|
$8.10 | -6.31% | 82.7K | $247.49M | 49 | Healthcare |
|
ARTV
Artiva Biotherapeutics, Inc.
|
$3.78 | -1.31% | 1.78M | $186.85M | 48 | Healthcare |
|
EVMN
Evommune, Inc.
|
$7.24 | +5.23% | 474.6K | $299.37M | 48 | Healthcare |
|
TELO
Telomir Pharmaceuticals, Inc.
|
$0.36 | -17.24% | 254.9K | $26.82M | 48 | Healthcare |
|
WHWK
Whitehawk Therapeutics Inc
|
$3.07 | -1.60% | 451.1K | $181.16M | 48 | Healthcare |
|
ATHE
Alterity Therapeutics Limited
|
$1.66 | -2.65% | 36.2K | $31.60M | 47 | Healthcare |
|
SABS
SAB Biotherapeutics, Inc.
|
$2.81 | -3.44% | 874.6K | $253.15M | 47 | Healthcare |
|
CRMD
CorMedix Inc.
|
$5.27 | +3.74% | 3.61M | $419.16M | 46 | Healthcare |
|
DYN
Dyne Therapeutics, Inc.
|
$15.50 | -3.31% | 2.23M | $2.90B | 46 | Healthcare |
|
LXEO
Lexeo Therapeutics
|
$2.96 | +0.34% | 1.80M | $245.05M | 46 | Healthcare |
|
MPLT
MapLight Therapeutics, Inc.
|
$5.94 | -7.48% | 357.9K | $330.12M | 46 | Healthcare |
|
NSRX
Nasus Pharma Ltd.
|
$2.29 | -10.20% | 34.0K | $26.82M | 46 | Healthcare |
|
SION
Sionna Therapeutics, Inc.
|
$2.83 | -4.88% | 547.7K | $127.79M | 46 | Healthcare |
|
TARA
Protara Therapeutics, Inc.
|
$2.28 | -5.00% | 1.07M | $140.38M | 46 | Healthcare |
|
CELC
Celcuity Inc.
|
$53.35 | -5.26% | 636.5K | $2.61B | 45 | Healthcare |
|
MLYS
Mineralys Therapeutics, Inc.
|
$13.66 | -3.53% | 1.35M | $1.21B | 45 | Healthcare |
|
OLMA
Olema Pharmaceuticals, Inc.
|
$7.02 | -1.82% | 1.26M | $615.00M | 45 | Healthcare |
|
IBO
Impact BioMedical Inc.
|
$6.17 | +25.66% | 25.2K | $53.31M | 44 | Healthcare |
|
MLTX
MoonLake Immunotherapeutics
|
$11.07 | +0.36% | 1.72M | $942.13M | 44 | Healthcare |
|
PEPG
PepGen Inc.
|
$3.78 | -3.82% | 4.43M | $356.31M | 44 | Healthcare |
|
VKTX
Viking Therapeutics, Inc.
|
$25.84 | -1.26% | 2.76M | $3.30B | 44 | Healthcare |
|
ACXP
Acurx Pharmaceuticals, Inc.
|
$1.04 | +0.97% | 153.8K | $6.30M | 43 | Healthcare |
|
ZURA
Zura Bio Limited
|
$0.95 | -1.32% | 2.08M | $91.74M | 42 | Healthcare |
|
FBIO
Fortress Biotech, Inc.
|
$1.90 | +7.34% | 739.1K | $64.11M | 41 | Healthcare |
|
CADL
Candel Therapeutics, Inc.
|
$5.04 | -1.75% | 1.72M | $395.37M | 40 | Healthcare |
|
JAZZ
Jazz Pharmaceuticals plc
|
$236.45 | -4.57% | 1.44M | $15.18B | 40 | Healthcare |
|
REPL
Replimune Group, Inc.
|
$19.07 | -0.83% | 1.96M | $1.81B | 40 | Healthcare |
|
TLX
Telix Pharmaceuticals Limited
|
$8.37 | -3.90% | 269.4K | $2.84B | 40 | Healthcare |
|
XERS
Xeris Biopharma Holdings, Inc.
|
$16.62 | -2.18% | 2.56M | $3.04B | 39 | Healthcare |
|
LEGN
Legend Biotech Corporation
|
$15.25 | -5.28% | 3.42M | $2.96B | 38 | Healthcare |
|
PCSA
Processa Pharmaceuticals, Inc.
|
$1.56 | -7.69% | 70.0K | $4.37M | 38 | Healthcare |
|
FBIOP
Fortress Biotech, Inc.
|
$13.60 | -1.09% | 27.7K | $56.53M | 37 | Healthcare |
|
ASMB
Assembly Biosciences, Inc.
|
$22.19 | -1.38% | 480.9K | $454.39M | 36 | Healthcare |
|
LQDA
Liquidia Corporation
|
$54.43 | -3.88% | 1.36M | $4.90B | 36 | Healthcare |
|
MDXG
MiMedx Group, Inc.
|
$3.05 | -1.93% | 2.12M | $445.07M | 36 | Healthcare |
|
ADPT
Adaptive Biotechnologies Corporation
|
$27.93 | -0.43% | 2.48M | $4.52B | 35 | Healthcare |
|
ALKS
Alkermes plc
|
$44.94 | -2.69% | 1.07M | $7.55B | 35 | Healthcare |
|
MDGL
Madrigal Pharmaceuticals, Inc.
|
$379.10 | -4.45% | 327.8K | $8.81B | 35 | Healthcare |
|
RNA
Avidity Biosciences, Inc.
|
$6.98 | +5.12% | 225.9K | $150.57M | 35 | Healthcare |
|
APLM
Apollomics, Inc.
|
$15.54 | -6.92% | 4.1K | $45.28M | 34 | Healthcare |
|
AXSM
Axsome Therapeutics, Inc.
|
$129.36 | -4.66% | 811.8K | $6.80B | 34 | Healthcare |
|
CUE
Cue Biopharma, Inc.
|
$4.15 | -7.78% | 1.26M | $34.69M | 34 | Healthcare |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
$10.69 | -1.75% | 15.0K | $43.69M | 34 | Healthcare |
|
GYRE
Gyre Therapeutics, Inc.
|
$4.21 | -6.86% | 240.1K | $460.79M | 34 | Healthcare |
|
IMA
ImageneBio Inc
|
$3.92 | +0.00% | 44.3K | $48.83M | 34 | Healthcare |
|
PBYI
Puma Biotechnology, Inc.
|
$7.05 | -0.98% | 861.2K | $364.47M | 34 | Healthcare |
|
PRTA
Prothena Corporation plc
|
$8.22 | -2.14% | 861.5K | $422.10M | 34 | Healthcare |
|
TVTX
Travere Therapeutics, Inc.
|
$47.00 | -2.69% | 1.33M | $4.51B | 34 | Healthcare |
|
UNCY
Unicycive Therapeutics, Inc.
|
$3.35 | -5.10% | 1.36M | $97.77M | 34 | Healthcare |
|
ALPS
Alps Group Inc
|
$1.15 | -3.36% | 49.2K | $36.43M | 33 | Healthcare |
|
ARVN
Arvinas, Inc.
|
$6.46 | -4.15% | 1.11M | $423.03M | 33 | Healthcare |
|
CAPR
Capricor Therapeutics, Inc.
|
$7.59 | +0.80% | 10.65M | $441.30M | 33 | Healthcare |
|
ENGN
enGene Holdings Inc.
|
$1.74 | -1.14% | 556.7K | $116.61M | 33 | Healthcare |
|
FLNA
Cassava Sciences, Inc. Common Stock
|
$0.64 | +14.52% | 1.32M | $32.26M | 33 | Healthcare |
|
GRI
GRI Bio, Inc.
|
$1.12 | +0.00% | 25.1K | $2.45M | 33 | Healthcare |
|
IMCR
Immunocore Holdings plc
|
$26.41 | -0.83% | 546.2K | $1.36B | 33 | Healthcare |
|
KLRS
Kalaris Therapeutics Inc
|
$1.28 | -5.19% | 38.0K | $30.47M | 33 | Healthcare |
|
MRVI
Maravai LifeSciences Holdings, Inc.
|
$6.98 | -2.92% | 1.79M | $1.81B | 33 | Healthcare |
|
NBTX
Nanobiotix S.A.
|
$26.50 | -2.98% | 125.3K | $1.35B | 33 | Healthcare |
|
NCEL
NewcelX Ltd.
|
$2.54 | -5.58% | 5.6K | $14.67M | 33 | Healthcare |
|
PYPD
PolyPid Ltd.
|
$6.12 | -6.56% | 448.9K | $129.29M | 33 | Healthcare |
|
TIL
Instil Bio, Inc.
|
$5.23 | -5.77% | 64.3K | $35.47M | 33 | Healthcare |
|
TVGN
Tevogen Bio Holdings Inc.
|
$5.90 | -6.35% | 9.4K | $405.20M | 33 | Healthcare |
|
ZYME
Zymeworks Inc.
|
$26.14 | -2.68% | 738.8K | $1.81B | 33 | Healthcare |
|
ABVC
ABVC BioPharma, Inc.
|
$0.87 | -1.56% | 39.1K | $23.37M | 32 | Healthcare |
|
ALDX
Aldeyra Therapeutics, Inc.
|
$0.84 | +16.39% | 2.41M | $50.70M | 32 | Healthcare |
|
ALEC
Alector, Inc.
|
$2.33 | +1.52% | 1.95M | $347.63M | 32 | Healthcare |
|
ALZN
Alzamend Neuro, Inc.
|
$0.78 | -23.94% | 93.1K | $3.74M | 32 | Healthcare |
|
APRE
Aprea Therapeutics, Inc.
|
$0.23 | -53.56% | 2.44M | $3.25M | 32 | Healthcare |
|
BNTX
BioNTech SE
|
$81.38 | -2.26% | 1.50M | $20.18B | 32 | Healthcare |
|
BYSI
BeyondSpring Inc.
|
$0.33 | -24.49% | 71.0K | $13.66M | 32 | Healthcare |
|
CGTX
Cognition Therapeutics, Inc.
|
$0.60 | +0.10% | 329.9K | $57.12M | 32 | Healthcare |
|
CLRB
Cellectar Biosciences, Inc.
|
$0.80 | -11.50% | 80.4K | $8.00M | 32 | Healthcare |
|
CMMB
Chemomab Therapeutics Ltd.
|
$1.19 | +4.39% | 70.8K | $9.58M | 32 | Healthcare |
|
GNPX
Genprex, Inc.
|
$1.67 | -2.34% | 63.5K | $2.23M | 32 | Healthcare |
|
INAB
IN8bio, Inc.
|
$0.76 | -1.86% | 37.2K | $8.19M | 32 | Healthcare |
|
IOVA
Iovance Biotherapeutics, Inc.
|
$6.90 | -5.61% | 13.73M | $3.19B | 32 | Healthcare |
Evidence & Sources
- Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.
- MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). Weights are rescaled to 100 when all five pillars have data: 28.3%, 21.7%, 19.6%, 17.4% and 13.0% of the score. It reads no news-sentiment or analyst data, and it is not a probability of future returns.
- Definitions follow standard investing terminology, with key terms explained inline in plain language where useful.
- Each price is the last quote we recorded, shown with the trading session it belongs to. Pages are served from a cache, so the copy you are reading can lag that quote. Each quote is a provider snapshot, not an exchange feed.
- This page is educational and does not constitute investment advice.
- Numbers come from market data providers (FMP); AI writes the plain-English explanations around them, which should be verified with independent research.
Prices: 2026-11-20 trading session · Company analysis text: updated 2026-06-15